Evidence map›Paper›PMID 35328834›Full record

ArticleInternational journal of molecular sciences2022

NKX2-5 Variant in Two Siblings with Thyroid Hemiagenesis.

Ewelina Szczepanek-Parulska, Bartłomiej Budny, Martyna Borowczyk, Igor Zhukov, Kosma Szutkowski, Katarzyna Zawadzka, Raiha Tahir, Andrzej Minczykowski, Marek Niedziela, Marek Ruchała

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ewelina Szczepanek-ParulskaDepartment of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Bartłomiej BudnyDepartment of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.ORCID 0000-0002-2860-395X
Martyna BorowczykDepartment of Medical Simulation, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Igor ZhukovPolish Academy of Sciences, Institute of Biochemistry and Biophysics, 02-106 Warsaw, Poland.ORCID 0000-0002-9912-1018
Kosma SzutkowskiNanoBioMedical Centre, Adam Mickiewicz University, 61-614 Poznan, Poland.ORCID 0000-0002-6091-9049
Katarzyna ZawadzkaMNM Diagnostics Sp. z o.o, 61-695 Poznan, Poland.
Raiha TahirDepartment of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Andrzej MinczykowskiDepartment of Intensive Cardiological Care and Internal Medicine, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Marek NiedzielaDepartment of Pediatric Endocrinology and Rheumatology, Institute of Pediatrics, Poznan University of Medical Sciences, 61-701 Poznan, Poland.ORCID 0000-0001-8862-6937
Marek RuchałaDepartment of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.ORCID 0000-0002-6296-7220
Poznan University of Medical Sciences · PLAdam Mickiewicz University in Poznań · PLInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PL

Funding

Polish National Center for Science MINIATURA 2 Grant number 2018/02/X/NZ5/00759
6 · The paper itself

Abstract

Thyroid hemiagenesis (THA) is an inborn absence of one thyroid lobe of largely unknown etiopathogenesis. The aim of the study was to reveal genetic factors responsible for thyroid maldevelopment in two siblings with THA. None of the family members presented with congenital heart defect. The samples were subjected to whole-exome sequencing (WES) (Illumina, TruSeq Exome Enrichment Kit, San Diego, CA 92121, USA). An ultra-rare variant c.839C>T (p.Pro280Leu) in NKX2-5 gene (NM_004387.4) was identified in both affected children and an unaffected father. In the mother, the variant was not present. This variant is reported in population databases with 0.0000655 MAF (GnomAD v3, dbSNP rs761596254). The affected amino acid position is moderately conserved (positive scores in PhyloP: 1.364 and phastCons: 0.398). Functional prediction algorithms showed deleterious impact (dbNSFP v4.1, FATHMM, SIFT) or benign (CADD, PolyPhen-2, Mutation Assessor). According to ACMG criteria, variant is classified as having uncertain clinical significance. For the first time, NKX2-5 gene variants were found in two siblings with THA, providing evidence for its potential contribution to the pathogenesis of this type of thyroid dysgenesis. The presence of the variant in an unaffected parent, carrier of p.Pro280Leu variant, suggests potential contribution of yet unidentified additional factors determining the final penetrance and expression.

Indexed as

SiblingsThyroid DysgenesisChildExomeHomeobox Protein Nkx-2.5HumansMutationHomeobox Protein Nkx-2.5NKX2-5 protein, humanNKX2-5 genethyroid dysgenesisthyroid hemiagenesisthyroid transcription factorwhole-exome sequencing

Identifiers

PMID35328834
PMCPMC8950672
OpenAlexW4220667265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.